Oslo, Norway, 30 April 2025: Photocure ASA (Photocure, PHO: OSE) will announce
the first quarter 2025 financial results on Thursday 8 May 2025 at 07:00 CEST
and will present a live webcast at 14:00 CEST the same day.
The quarterly report and presentation will be published at 07:00 CEST and will
be publicly available at www.photocure.com.
The investor presentation will be streamed live and be hosted by Dan Schneider,
CEO and Erik Dahl, CFO. The presentation will be held in English and questions
can be submitted throughout the event. The presentation is scheduled to conclude
at 14:45 CEST.
The streaming event is available through
https://channel.royalcast.com/landingpage/hegnarmedia/20250508_10/ (https://eur01
.safelinks.protection.outlook.com/?url=https%3A%2F%2Fchannel.royalcast.com%2Fland
ingpage%2Fhegnarmedia%2F20250508_10%2F&data=05%7C02%7CTH%40photocure.no%7C8aa7e11
484d8472bc80408dd6fd632aa%7C0986794f1d6f488980bd853c0715d3c1%7C0%7C0%7C6387896879
59346968%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAi
OiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=iyu4p8tzjf2OQepab
GoK5EmDuvpud77Blr9LnBEy2i0%3D&reserved=0)
For further information, please contact:
Photocure
Erik Dahl
CFO
Tel: +47 45055000
Email: ed@photocure.com
Jonas Fougner
Interim IRO
Tel: +47 94805851
Email: jonas.fougner@photocure.com
Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway) Tel: +47 91540000
Email: geir.bjorlo@corpcom.no
About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com and www.cysview.com.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.